Navigation Links
Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise
Date:3/10/2009

CARMEL, Ind., March 10 /PRNewswire/ -- Christine Lawless, MD, has accepted the position as Medical Director of CME Enterprise, an ACCME-accredited provider of continuing medical education (CME), beginning March 2, 2009. Recognized as one of the world's leading authorities in sports medicine cardiology, Dr. Lawless recently completed her clinical tenure at The Ohio State University Medical Center, where she was Associate Professor of Internal Medicine and Co-Director of Ross Heart Hospital Lipid Clinic.

"Placing Dr. Lawless as Medical Director greatly increases opportunities to engage in cardiovascular and sports medicine, ensuring that the CME Enterprise team will continue its growth as a consummate professional education resource for quality CME," said CME Enterprise owner Deborah Wood.

"I look forward to working with my new colleagues at CME Enterprise as we continue to develop the most relevant curriculum for healthcare professionals," said Dr. Lawless. "The areas of greatest interest and expertise that I bring to CME Enterprise include preventive cardiology, lipids, hypertension, cardiomyopathy, heart disease in athletes, sports cardiology, sudden cardiac arrest and sports medicine."

Dr. Lawless is board certified in internal medicine, cardiovascular disease clinical lipidology¸ and sports medicine. She also is Chair of the US Figure Skating Sports Sciences and Sports Medicine Committee and also Head Team Physician for US Figure Skating. Dr. Lawless serves on the Advisory Board for the National Sudden Cardiac Arrest Association. She holds many other appointments in academic medicine and hospital-based clinical care. "With her expertise and extensive experience in academic and clinical medicine, Dr. Lawless will enable CME Enterprise to establish educational excellence not only in cardiovascular science, but also internal sports medicine for athletes," said CME Enterprise President Bruce J. Bellande, PhD, FACME, CCMEP.

About CME Enterprise

CME Enterprise, an innovative education company, is an ACCME-accredited provider with Exemplary Status in Mission, Needs Assessment, and Effective Measurement of Activities. CME Enterprise develops extensive needs assessments, executes needs-based and competency-based curricula, and impacts physician knowledge and patient outcomes through local, national, and international CME interventions. By engaging in continuous clinical practice performance improvement and healthcare systems quality improvement, CME Enterprise has set itself apart from other medical education companies. For more information about CME Enterprise, visit its Web site at www.cmeenterprise.com.

    Media contact:
    McKenna Goslee
    (317) 846-2879


'/>"/>
SOURCE CME Enterprise
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
4. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
7. Former Patent Office Solicitor and Judge Joins Rothwell Figg
8. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
9. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
10. Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
11. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... OXFORD, England , December 8, 2016 /PRNewswire/ ... (OGT), das Unternehmen für Molekulargenetik, erweitert seine Palette ... SureSeq myPanel™ NGS Custom FH Panels, das ein ... Hypercholesterinämie (FH) ermöglicht. Das Panel bietet eine Erkennung ... Number Variations (CNV) mit einem einzigen kleinen Panel ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox ... response to client demand KbioBox developed a sophisticated “3 click” gene dditing off ... accessible from KBioBox’s new website, https://www.kbiobox.com/ and powered by the ...
(Date:12/8/2016)... ... ... This CAST literature review and report looks at problems caused by the current ... in countries that are major global commodity exporters and importers, which show that asynchrony ... level presence (LLP) puts large volumes of trade worth billions of dollars at risk. ...
(Date:12/8/2016)... TAMPA, Fla. , Dec. 8, 2016 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that its shares of common stock were approved ... stock will begin trading on the OTCQX, effective ... To qualify for the OTCQX market, companies must ...
Breaking Biology Technology:
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):